Conexeu Sciences issues 4.34M shares on warrant exercise, raises ~$1.96M; amends bylaws to increase quorum

Conexeu Sciences Inc.

Issued 4,342,648 common shares upon exercise of warrants for aggregate gross proceeds of ~$1,963,967.
Issued 4,342,648 Incentive Warrants exercisable at $2.30/share for 36 months as inducement.
Bylaws amended to increase stockholder meeting quorum from 5% to 33.3% to comply with Nasdaq Rule 5620(c).
Also issued 11,175 shares at $4.00 to a director for compensation on May 14, 2026.
Proceeds for working capital; 827,005 Program Warrants remain outstanding.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Conexeu Sciences Inc.: Increased quorum requirement for stockholder meetings from one-twentieth to one-third of outstanding shares (effective 2026-05-11).

Change: bylaw amendment
Effective: 2026-05-11

Exact text from the filing

On May 11, 2026, the Board of Directors of the Company approved an amendment to the bylaws (the " Bylaws ") of the Company in order to increase the quorum requirement for meetings of stockholders from one-twentieth (1/20) of the outstanding shares of the Company entitled to vote at any such meeting, represented in person or by proxy, to one-third (331⁄3%) of the outstanding shares of the Company entitled to vote, represented in person or by proxy.

View on SEC.gov

Browse all governance changes →

Conexeu Sciences Inc. filing history →

Source: SEC EDGAR

accession 0001062993-26-002703

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.